Future-Fit
A comprehensive 6-month, doctor-led digital weight loss program paired with GLP-1 medication, designed to complement your existing insurance coverage.
Evidence-Based Clinical Results
Future-Fit is built on proven clinical evidence demonstrating significant health improvements.
Paired with GLP-1
With robust evidence after 4-17 months. 1-4
Conveniently dosed at once a week.
Angsana Health’s Future-Fit is Designed to be
Safe & Effective
Convenient
Sustainable
References:
1 KKM and Malaysia Endocrine and Metabolic Society: Management of Obesity 2nd Ed. (2023)
2 STEP-3 Trial: Wadden et al (2021) Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity. JAMA. n=611.
3 STEP-1 Trial: Wilding, et al (2021). Once-Weekly Semaglutide in Adults with Obesity. NEJM. n=1961
4 STEP-6 Trial. Kadowaki et al (2022). The Lancet Diabetes & Endocrinology. n=437
5 Kahn et al (2024). Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial. Diabetes Care. n=17,604
6 SELECT Trial: Lincoff et al (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM. n=17,604
Angsana Future-Fit
A Complete 6-Month Weight Loss System that Complements Your Insurance Coverage
5 comprehensive components, including GLP-1 medication and clinical care.
Digital Tools
Medicines
Consultations
Personalized Diet Plan
Exercise Plan
References:
1 Wilding, et al (2021). Once-Weekly Semaglutide in Adults with Obesity. NEJM, 384(11), 989–1002.
2 Adults taking Wegovy® had an average weight loss of 14.9% from baseline, versus 2.4% for placebo.
Delivered through a trusted network of partner clinics, Future-Fit combines expert medical care with clinically proven treatment to drive real, lasting health outcomes.



Your Future-Fit Journey
Meet inclusion criteria, complete payment, and get matched with your dedicated clinical team who will support you throughout your journey.
Begin with a comprehensive GP assessment leading to an e-prescription for GLP-1 medication. Regular consultations with your clinical team ensure safe, effective progress.
Target Weight Achieved
Convert to Future-Fit Plus (medication only) for continued maintenance.
Target Not Achieved
Repeat the 6-month program or receive specialist referral for additional support.


Future-Fit is Affordable & Flexible
Future-Fit is approximately 25% more affordable than the market average of RM 7,831*
RM 5880
Angsana Future-Fit Price
- GLP-1 medication
- 4X GP tele-consults
- 3X Dietitian tele-consults
- 1X Pharmacist consult
- Digital Health Tools
~RM 7831
Market Price*
- GLP-1 medication
- 2 - 3X GP tele-consults
- Dietitian consult
- Pharmacist consult
- Digital Health Tools
*Market average of RM 7831 based on comparable 6-month programs Based on desk research conducted in Mar 2026 (n=9).
Choose from 3 Payment Options
Designed to fit different company budgets, with flexible payment structures to support both employers and employees.
Option A
Full Payment Model
Company fully funds the program for employees.
Option B
Subsidized Model
Company subsidizes a portion while employees cover the remaining cost.
Option C
Instalment Basis
Full coverage or co-payment model can be split into manageable monthly payments.
This is a data-informed estimate based on Malaysian workforce averages, healthcare trends, and clinical outcomes. Actual results may vary by company.
Get in Touch with Us
Complete a short screening form and our team will recommend a plan based on your company’s needs.


Frequently Asked Questions
Who is not eligible for Future-Fit?
The program is not suitable for individuals with: BMI < 25, personal or family history of medullary thyroid cancer, MEN-2 syndrome, planned pregnancy within 2 months, diabetes, or known allergies to GLP-1 medication.
What is the time requirement to undergo Future-Fit?
A 6-month program featuring 7 scheduled teleconsultations (4 with GP, 3 with Dietitian, plus 1 pharmacist session), all coordinated by a dedicated Care Coordinator to ensure seamless scheduling.
Is the medication self-administered?
Yes, but the first dose is guided by a pharmacist who provides comprehensive training on safe dosing techniques and proper administration methods.
Do users continue GLP-1 treatment after the program?
Yes. There will be Future-Fit Plus (medication only), where users can continue their supply of Wegovy upon successful completion of 6 months Future-Fit.
Where and how do I collect my medication?
After your GP teleconsultation, an e-prescription is sent directly via Future-Fit WebApp to a nearby pharmacy in our network for convenient local collection.


































































